Sam Schulman graduated from Karolinska Institutet, Stockholm, Sweden in 1977 and became a specialist in Internal Medicine in 1984, with subspecialties in Hematology and in Coagulation in 1985. That year he also received his Dr Med Sc with the thesis: “Studies on the Medical Treatment of Deep Vein Thrombosis”. He has worked within the field of coagulation disorders continuously since 1984 and was director of the Hemophilia Treatment Center in Stockholm 1996 to 2004. His major research activities have been clinical studies in venous thromboembolism, including several randomized trials, and in hemophilia and its complications. He is currently involved in trials with new antithrombotic agents, such as the oral thrombin inhibitors.
Sam Schulman has been a member of the Executive Committee of the World Federation of Hemophilia (2000-2004) and was chairman of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of ISTH 2005-2008. He was President for the XXV ISTH Congress in Toronto, 2015. He is a member of the ISTH Council since 2013, and ISTH Treasurer. Dr. Schulman is associate professor in Internal Medicine at Karolinska Institute and since September 2004 also professor in Medicine at McMaster University. He is Director of the Thrombosis Service at HHS-General Hospital in Hamilton since 2004 and was Director of the Clinical Thromboembolism Program of McMaster University 2007-2018. Moreover, he is professor at the Department of Obstetrics and Gynaecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.
Sam Schulman has published over 250 original articles, 140 review articles or book chapters and is co-editor of the most recent, 6th, edition of the textbook Haemostasis and Thrombosis – Basic Principles and Clinical Practice.